Champions Oncology Inc (CSBR)

Name: Champions Oncology Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-01-31

Latest Quarter

2026-01-31

Revenue

$16.6M

Net Income

-$279K

Operating Margin

-1.1%

Free Cash Flow

$7.0M

Debt / Assets

88.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Champions Oncology Inc (CSBR).
Income Statement (Quarterly)	2026-01-31	2025-10-31	2025-07-31	2025-01-31
Revenue	16,559,000	15,035,000	13,995,000	17,039,000
Cost of Revenue	9,175,000	7,619,000	8,353,000	6,617,000
Gross Profit	7,384,000	7,416,000	5,642,000	10,422,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	5,641,000	4,972,000	4,067,000	4,204,000
Operating Expenses	7,571,000	7,231,000	6,149,000	5,923,000
Operating Income	-187,000	185,000	-507,000	4,499,000
Interest Expense	0	0	0	0
Income Before Tax	-237,000	255,000	-452,000	4,518,000
Income Tax Expense	42,000	18,000	14,000	23,000
Net Income	-279,000	299,000	-436,000	4,495,000
Per Share
EPS	-0.02	0.02	-0.03	0.33
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Champions Oncology Inc (CSBR).
Income Statement (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Revenue	56,944,000	50,155,000	53,870,000	49,109,000	41,040,000
Cost of Revenue	30,029,000	29,401,000	29,532,000	23,632,000	21,446,000
Gross Profit	26,915,000	20,754,000	24,338,000	25,477,000	19,594,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	15,244,000	18,131,000	17,242,000	15,496,000	12,032,000
Operating Expenses	22,069,000	27,675,000	28,787,000	24,870,000	19,228,000
Operating Income	4,846,000	-6,921,000	-4,449,000	607,000	366,000
Interest Expense	27,000	28,000	0	24,000	0
Income Before Tax	4,626,000	-7,308,000	-5,267,000	583,000	437,000
Income Tax Expense	-75,000	-32,000	68,000	35,000	75,000
Net Income	4,701,000	-7,276,000	-5,335,000	548,000	362,000
Per Share
EPS	0.34	-0.54	-0.39	0.04	0.03
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Champions Oncology Inc (CSBR).
Balance Sheet (Quarterly)	2025-04-30	2024-04-30	2023-04-30	2022-04-30
Assets
Cash and Cash Equivalents	9,785,000	2,618,000	10,118,000	9,007,000
Short Term Investments	0	0	0	0
Net Receivables	11,234,000	9,526,000	8,011,000	9,513,000
Inventory	0	0	1	0
Total Current Assets	22,369,000	13,639,000	19,457,000	19,664,000
Property Plant Equipment	9,455,000	11,973,000	14,504,000	15,364,000
Goodwill and Intangibles	335,000	335,000	335,000	335,000
Total Assets	32,344,000	26,132,000	34,311,000	35,378,000
Liabilities
Account Payables	4,248,000	5,800,000	5,334,000	2,868,000
Short Term Debt	1,471,000	1,337,000	1,208,000	1,054,000
Total Current Liabilities	23,853,000	21,541,000	21,733,000	17,479,000
Long Term Debt	4,634,000	6,093,000	7,391,000	8,412,000
Total Liabilities	28,572,000	28,035,000	29,675,000	26,282,000
Shareholders Equity
Retained Earnings	-79,892,000	-84,593,000	-77,317,000	-71,982,000
Total Shareholders Equity	3,772,000	-1,903,000	4,636,000	9,096,000

Balance sheet annual history for Champions Oncology Inc (CSBR).
Balance Sheet (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Assets
Cash and Cash Equivalents	9,785,000	2,618,000	10,118,000	9,007,000	4,687,000
Short Term Investments	0	0	0	0	0
Net Receivables	11,234,000	9,526,000	8,011,000	9,513,000	6,986,000
Inventory	0	0	1	0	0
Total Current Assets	22,369,000	13,639,000	19,457,000	19,664,000	12,630,000
Property Plant Equipment	9,455,000	11,973,000	14,504,000	15,364,000	14,611,000
Goodwill and Intangibles	335,000	335,000	335,000	335,000	335,000
Total Assets	32,344,000	26,132,000	34,311,000	35,378,000	27,591,000
Liabilities
Account Payables	4,248,000	5,800,000	5,334,000	2,868,000	1,894,000
Short Term Debt	1,471,000	1,337,000	1,208,000	1,054,000	818,000
Total Current Liabilities	23,853,000	21,541,000	21,733,000	17,479,000	11,199,000
Long Term Debt	4,634,000	6,093,000	7,391,000	8,412,000	8,783,000
Total Liabilities	28,572,000	28,035,000	29,675,000	26,282,000	20,163,000
Shareholders Equity
Retained Earnings	-79,892,000	-84,593,000	-77,317,000	-71,982,000	-72,530,000
Total Shareholders Equity	3,772,000	-1,903,000	4,636,000	9,096,000	7,428,000

Cash flow quarterly history for Champions Oncology Inc (CSBR).
Cash Flow Statement (Quarterly)	2025-04-30	2024-04-30	2023-04-30	2022-04-30
Operating Activities
Net Income	4,701,000	-7,276,000	-5,335,000	548,000
Depreciation & Amortization	1,640,000	1,867,000	2,246,000	1,627,000
Stock Based Compensation	654,000	1,118,000	864,000	912,000
Change in Working Capital	-621,000	-3,823,000	4,226,000	2,336,000
Operating Cash Flow	7,386,000	-6,137,000	3,955,000	6,497,000
Investing Activities
Capital Expenditure	-389,000	-836,000	-2,872,000	-2,384,000
Investments	-389,000	-836,000	-2,872,000	-2,384,000
Investing Cash Flow	-389,000	-836,000	-2,872,000	-2,384,000
Financing Activities
Debt Repayment	-150,000	-146,000	0	0
Common Stock Issued/Repurchased	320,000	-634,000	11,000	207,000
Dividends Paid	0	0	0	0
Financing Cash Flow	170,000	-527,000	11,000	207,000
Summary
Free Cash Flow	6,997,000	-6,973,000	1,083,000	4,113,000
Net Change in Cash	7,167,000	-7,500,000	1,094,000	4,320,000

Cash flow annual history for Champions Oncology Inc (CSBR).
Cash Flow Statement (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Operating Activities
Net Income	4,701,000	-7,276,000	-5,335,000	548,000	362,000
Depreciation & Amortization	1,640,000	1,867,000	2,246,000	1,627,000	1,184,000
Stock Based Compensation	654,000	1,118,000	864,000	912,000	598,000
Change in Working Capital	-621,000	-3,823,000	4,226,000	2,336,000	-4,197,000
Operating Cash Flow	7,386,000	-6,137,000	3,955,000	6,497,000	-1,681,000
Investing Activities
Capital Expenditure	-389,000	-836,000	-2,872,000	-2,384,000	-3,281,000
Investments	-389,000	-836,000	-2,872,000	-2,384,000	-3,281,000
Investing Cash Flow	-389,000	-836,000	-2,872,000	-2,384,000	-3,169,000
Financing Activities
Debt Repayment	-150,000	-146,000	0	0	-174,000
Common Stock Issued/Repurchased	320,000	-634,000	11,000	207,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	170,000	-527,000	11,000	207,000	1,195,000
Summary
Free Cash Flow	6,997,000	-6,973,000	1,083,000	4,113,000	-4,962,000
Net Change in Cash	7,167,000	-7,500,000	1,094,000	4,320,000	-3,655,000